Klisyri Side Effects
Generic name: tirbanibulin topical
Medically reviewed by Drugs.com. Last updated on Aug 10, 2022.
Note: This document contains side effect information about tirbanibulin topical. Some dosage forms listed on this page may not apply to the brand name Klisyri.
Applies to tirbanibulin topical: topical application ointment.
Serious side effects of Klisyri
Along with its needed effects, tirbanibulin topical (the active ingredient contained in Klisyri) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking tirbanibulin topical:
- Cracking of the skin
- crusting of the skin
- dryness and peeling of the skin
- flushing, redness of the skin
- redness, blistering, peeling, or loosening of the skin
- skin ulcers
- unusually warm skin
Other side effects of Klisyri
Some side effects of tirbanibulin topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Burning, stinging, or pain at the application site
- itching skin
For Healthcare Professionals
Applies to tirbanibulin topical: topical ointment.
Very common (10% or more): Adverse reaction related to treatment (16%)[Ref]
Very common (10% or more): Erythema (mild: 22%; moderate: 63%; severe: 6%), flaking/scaling (mid: 26%; moderate: 47%), crusting (mild: 30%; moderate: 14%), swelling (mild: 29%)
Common (1% to 10%): Flaking/scaling (severe: 9%), crusting (severe: 2%), swelling (mild: 9%; severe: <1%), vesiculation/pustulation (mild:7%; moderate to severe: <1%; ), erosion/ulceration (mild: 9%; moderate: 3%), application site pruritus (9%), application site pain (pain, tenderness, stinging, and burning sensation: 10%)[Ref]
More about Klisyri (tirbanibulin topical)
- Pricing & coupons
- Reviews (1)
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: topical antineoplastics
- En español
Related treatment guides
1. "Product Information. Klisyri (tirbanibulin topical)." Almirall (2021):
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.